高血压治疗进展

[1] 螺内酯对继发性高血压大鼠肾脏的保护作用 [J]. 中华高血压杂志, 2008, 16 (01) : 46 - 50

[2] 血管紧张素(1～7)防止血管紧张素Ⅱ诱导的心肌细胞凋亡 [J]. 中华高血压杂志, 2008, 16 (01) : 65 - 69

[3] 缓激肽在血管紧张素(1～7)保护血管内皮细胞中的作用 [J]. 中华高血压杂志, 2007, (01) : 44 - 48

[4] β受体阻滞剂治疗高血压过时了吗?———评英国高血压指南 [J]. 中华内科杂志, 2006, (12) : 971 - 973

[5] Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial[J] . Stevo Julius,Sverre E Kjeldsen,Michael Weber,Hans R Brunner,Steffan Ekman,Lennart Hansson,Tsushung Hua,John Laragh,Gordon T McInnes,Lada Mitchell,Francis Plat,Anthony Schork,Beverly Smith,Alberto Zanchetti.The Lancet . 2004 (9426)

[6] Angiotensin-Converting Enzyme Inhibitors and Stroke Prevention: What About the Influence of Atrial Fibrillation and Antithrombotic Therapy?[J] . Stroke: Journal of the American Heart Association . 2003 (11)

[7] Comparison of nifedipine re-tard with angiotensin converting enzyme inhibitors in Japanese hy-pertensive patients with coronary artery disease:the Japan Multi-center Investigation for Cardiovascular Diseases-B（JMIC-B）ran-domized trial. YuiY,Sumiyoshi T,Kodama K,et al. Hypertension Research . 2004

[8] Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. Nissen S E, Tuscou E M, Libby P, et al. The Journal of The American Medical Association . 2004

[1] 螺内酯对继发性高血压大鼠肾脏的保护作用 [J]. 中华高血压杂志, 2008, 16 (01) : 46 - 50

[2] 血管紧张素(1～7)防止血管紧张素Ⅱ诱导的心肌细胞凋亡 [J]. 中华高血压杂志, 2008, 16 (01) : 65 - 69

[3] 缓激肽在血管紧张素(1～7)保护血管内皮细胞中的作用 [J]. 中华高血压杂志, 2007, (01) : 44 - 48

[4] β受体阻滞剂治疗高血压过时了吗?———评英国高血压指南 [J]. 中华内科杂志, 2006, (12) : 971 - 973

[5] Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial[J] . Stevo Julius,Sverre E Kjeldsen,Michael Weber,Hans R Brunner,Steffan Ekman,Lennart Hansson,Tsushung Hua,John Laragh,Gordon T McInnes,Lada Mitchell,Francis Plat,Anthony Schork,Beverly Smith,Alberto Zanchetti.The Lancet . 2004 (9426)

[6] Angiotensin-Converting Enzyme Inhibitors and Stroke Prevention: What About the Influence of Atrial Fibrillation and Antithrombotic Therapy?[J] . Stroke: Journal of the American Heart Association . 2003 (11)

[7] Comparison of nifedipine re-tard with angiotensin converting enzyme inhibitors in Japanese hy-pertensive patients with coronary artery disease:the Japan Multi-center Investigation for Cardiovascular Diseases-B（JMIC-B）ran-domized trial. YuiY,Sumiyoshi T,Kodama K,et al. Hypertension Research . 2004

[8] Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. Nissen S E, Tuscou E M, Libby P, et al. The Journal of The American Medical Association . 2004